The woman is the first UK patient to receive the new device as part of a Europe-wide clinical trial. It offers people with geographic atrophy (GA), the most common form of dry age-related macular degeneration (AMD), the hope of regaining some of their lost sight.
The procedure involves inserting a 2mm wide microchip under the centre of a patient’s retina, by surgically creating a trapdoor into which the chip is posted.
The patient uses special glasses, containing a video camera that is connected to a small computer attached to their waistband. The chip captures the visual scene projected by the glasses and transmits this to the computer.
Artificial intelligence (AI) algorithms process this information and instruct the glasses to focus...